DNLI   $20.47  3.80% Market Closed After Close 20.38 -0.44%

Denali Therapeutics Inc.

EMA (20): 2026-08-28 the price crossed down the moving average line and demonstrates a strong downside trend.

EMA (50): 2026-08-31 the price crossed down the moving average line and demonstrates a strong downside trend.

EMA (100): 2026-09-04 the price crossed down the moving average line and formed a short-term downside trend.

RSI: RSI indicator is in the lower part of the neutral territory and it heading south. These factors indicate that negative dynamics is recovering. Last signal: exit from the overbought zone.

MACD: Oscillator MACD is in the negative territory it's lower than the signal line and falls. These factors mean that negative mood prevails. Last signal: entry into the oversold zone.

Stochastic: The stochastic indicator is in the oversold territory and it heading north. These factors indicate that perhaps the downside trend is coming to an end. Last signal: main and signal line crossing.

Trend Type up and flat
Power strong
Trend Pattern
EMA (20) Signals bearish reversal
EMA (20) Yield -17.83%
EMA (20) date of signal Aug. 28, 2026, 3 a.m.
EMA (50) Signals bearish reversal
EMA (50) Yield -17.00%
EMA (50) date of signal Aug. 31, 2026, 3 a.m.
EMA (100) Signals bearish reversal
EMA (100) Yield -11.49%
EMA (100) date of signal Sept. 4, 2026, 3 a.m.
RSI Signals bearish recovery
RSI (14) Yield 0.0
RSI (14) date of signal Sept. 18, 2026, 3 a.m.
MACD Signals bearish
MACD Yield -10.69%
MACD date of signal Sept. 8, 2026, 3 a.m.
Stochastic Signals bearish recovery
Stochastic Yield -2.04%
Stochastic date of signal Sept. 17, 2026, 3 a.m.
Updated Sept. 20, 2026, 11 p.m.